secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0001628280-25-020477
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx appoints Merdad Parsey to Board of Directors, effective April 28, 2025
------------------------------------------------------------------------------

- Merdad Parsey, M.D., Ph.D., appointed as Class I director, effective April 28, 2025.
- Also appointed to Nominating and Corporate Governance Committee effective June 18, 2025.
- Initial equity compensation: option and RSUs each valued at ~$225,000, plus annual cash retainers of $50k (board) and $5k (committee).
- Dr. Parsey is independent per Nasdaq Listing Rule 5605.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025020477/0001628280-25-020477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025020477/ardx-20250428.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-020477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer